PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,612,000 | -21.7% | 519,100 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $3,337,000 | -28.9% | 519,100 | -22.2% | 0.01% | -22.2% |
| Q1 2015 | $4,694,000 | -5.9% | 667,300 | +3.2% | 0.01% | -10.0% |
| Q4 2014 | $4,988,000 | +3.2% | 646,900 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $4,832,000 | -17.4% | 646,900 | +7.0% | 0.01% | -23.1% |
| Q2 2014 | $5,852,000 | -5.9% | 604,500 | -19.2% | 0.01% | -7.1% |
| Q1 2014 | $6,216,000 | +1163.4% | 748,000 | +1183.0% | 0.01% | +1300.0% |
| Q4 2013 | $492,000 | +4.2% | 58,301 | -1.5% | 0.00% | 0.0% |
| Q3 2013 | $472,000 | -64.8% | 59,176 | -66.0% | 0.00% | -75.0% |
| Q2 2013 | $1,342,000 | – | 173,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |